Loading insider details...
Beta
Latest Form 4 (Jan 9, 2026): Grant/Award of 50,000 SLS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 9, 2026 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 50,000 | n/a |
| Jun 13, 2025 | SELLAS Life Sciences Group, Inc. (SLS) | Purchase | 10,000 | $14.8K |
| Jan 14, 2025 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 12,500 | n/a |
| Jul 2, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/Award | 83 | $5.7K |
| Jun 25, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 1,567 | n/a |
| Jun 21, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 20,000 | $337.2K |
| Jun 18, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/Award | 2,951 | n/a |
| Apr 2, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/Award | 79 | $5.5K |
| Apr 1, 2024 | YIELD10 BIOSCIENCE, INC. (YTEN) | Grant/Award | 11,924 | n/a |
| Feb 28, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 20,000 | $371.2K |